secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001213900-26-015212
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix to acquire Realbotix in reverse merger; Realbotix holders to own 75-90%
--------------------------------------------------------------------------------

- Onconetix issues shares to Realbotix seller such that seller owns 75%–90% of fully diluted shares based on Net Cash at closing.
- Closing requires Onconetix to have at least $12.5M Net Cash and enter a $125M equity line of credit.
- Post-closing board: 5 directors with 4 designated by Realbotix and 1 by Onconetix.
- Realbotix is an AI humanoid robotics company with U.S. manufacturing, proprietary AI, and multilingual robots.
- Termination fee: $500k plus expenses (capped at $500k); additional $1.5M if Buyer Superior Proposal closes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026015212/0001213900-26-015212-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026015212/ea0276704-8k425_onconet.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-015212

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer